» Articles » PMID: 10574970

LAT2, a New Basolateral 4F2hc/CD98-associated Amino Acid Transporter of Kidney and Intestine

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1999 Nov 27
PMID 10574970
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

Glycoprotein-associated amino acid transporters (gpaAT) are permease-related proteins that require heterodimerization to express their function. So far, four vertebrate gpaATs have been shown to associate with 4F2hc/CD98 for functional expression, whereas one gpaAT specifically associates with rBAT. In this study, we characterized a novel gpaAT, LAT2, for which mouse and human cDNAs were identified by expressed sequence tag data base searches. The encoded ortholog proteins are 531 and 535 amino acids long and 92% identical. They share 52 and 48% residues with the gpaATs LAT1 and y(+)LAT1, respectively. When mouse LAT2 and human 4F2hc cRNAs were co-injected into Xenopus oocytes, disulfide-linked heterodimers were formed, and an L-type amino acid uptake was induced, which differed slightly from that produced by LAT1-4F2hc: the apparent affinity for L-phenylalanine was higher, and L-alanine was transported at physiological concentrations. In the presence of an external amino acid substrate, LAT2-4F2hc also mediated amino acid efflux. LAT2 mRNA is expressed mainly in kidney and intestine, whereas LAT1 mRNA is expressed widely. Immunofluorescence experiments showed colocalization of 4F2hc and LAT2 at the basolateral membrane of kidney proximal tubules and small intestine epithelia. In conclusion, LAT2 forms with LAT1 a subfamily of L-type gpaATs. We propose that LAT1 is involved in cellular amino acid uptake, whereas LAT2 plays a role in epithelial amino acid (re)absorption.

Citing Articles

Integration of machine learning and experimental validation to identify the prognostic signature related to diverse programmed cell deaths in breast cancer.

Li L, Zhao J, Wang Y, Zhang Z, Chen W, Wang J Front Oncol. 2025; 14():1505934.

PMID: 39834939 PMC: 11744720. DOI: 10.3389/fonc.2024.1505934.


A monoclonal antibody recognizing CD98 on human embryonic stem cells shows anti-tumor activity in hepatocellular carcinoma xenografts.

Lim K, Han S, Han S, Lee J, Choi H, Choi D Cancer Immunol Immunother. 2024; 73(11):231.

PMID: 39261363 PMC: 11390997. DOI: 10.1007/s00262-024-03827-x.


Molecular Variability in Levodopa Absorption and Clinical Implications for the Management of Parkinson's Disease.

Pedrosa de Menezes A, Bloem B, Beckers M, Piat C, Benarroch E, Savica R J Parkinsons Dis. 2024; 14(7):1353-1368.

PMID: 39240647 PMC: 11492115. DOI: 10.3233/JPD-240036.


Evidence for a relationship between genetic polymorphisms of the L-DOPA transporter LAT2/4F2hc and risk of hypertension in the context of chronic kidney disease.

Crocco P, Dato S, La Grotta R, Passarino G, Rose G BMC Med Genomics. 2024; 17(1):163.

PMID: 38890684 PMC: 11186288. DOI: 10.1186/s12920-024-01935-2.


Astrocyte-Neuron Interaction via the Glutamate-Glutamine Cycle and Its Dysfunction in Tau-Dependent Neurodegeneration.

Sidoryk-Wegrzynowicz M, Adamiak K, Struzynska L Int J Mol Sci. 2024; 25(5).

PMID: 38474295 PMC: 10931567. DOI: 10.3390/ijms25053050.